CATALAYER NEWS
Amgen: Why Rivals' Cholesterol Drug Fail Is Bad News For The Pharma (Rating Downgrade)
Source: Seeking Alpha · 2026-09-08
Full article text is available in the Catalayer news terminal.
MORE FROM SEEKING ALPHA
Payroll Boom, Warsh Hawkish, Iran On Fire: The Perfect Storm For FLBL's Leveraged Loans
2026-09-10
Palantir: An Elite Business Heading Into A Valuation Reset (Rating Downgrade)
2026-09-10
Cohu: 80% Utilization Matters More Than The $850 Million AI Pipeline
2026-09-10
Nomad Foods: Frozen Stock, Hot Opportunity
2026-09-10
Toast: This Quickly Turned Into My Favorite Fintech Play
2026-09-10
RELATED ON CATALAYER
Mentioned Tickers
$AMGN · AmgenRelated Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets